Literature DB >> 22830201

Cholesterol-lowering activity of lactic acid bacteria probiotic strains in vivo.

S A Starovoitova1, L P Babenko, N A Timoshok, L N Shynkarenko, L N Lazarenko, N Y Spivak.   

Abstract

Cholesterol-lowering activity of probiotic strains of lactic acid bacteria genera Lactobacillus and Bifidobacterium in the in vivo experiments on the model of experimental hypercholesterolemia in mice was studied. It is established that the prophylactic scheme of introduction of probiotic cultures is more effective than therapeutic one for the manifestation of cholesteraze activity of probiotic cultures. The most effective were the cultures: L. acidophilus and B. bifidum, as well as the composition B. bifidum + B. longum. Cholesterol-lowering activity of the studied strains and their compositions in this experiment ranged between 40-78%. It is noted that cholesteraze activity of other studied strains was not lower and in some cases, higher than that of most of the drugs currently used in cholesterinozis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22830201

Source DB:  PubMed          Journal:  Mikrobiol Z        ISSN: 1028-0987


  3 in total

1.  The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention.

Authors:  Oleksandr A Savcheniuk; Oleksandr V Virchenko; Tetyana M Falalyeyeva; Tetyana V Beregova; Lidia P Babenko; Liudmyla M Lazarenko; Olga M Demchenko; Rostyslav V Bubnov; Mykola Ya Spivak
Journal:  EPMA J       Date:  2014-01-13       Impact factor: 6.543

2.  Relationship Between Putative eps Genes and Production of Exopolysaccharide in Lactobacillus casei LC2W.

Authors:  Xin Song; Zhiqiang Xiong; Linghui Kong; Guangqiang Wang; Lianzhong Ai
Journal:  Front Microbiol       Date:  2018-08-17       Impact factor: 5.640

3.  Probiotics and immunity: provisional role for personalized diets and disease prevention.

Authors:  Rostyslav V Bubnov; Mykola Ya Spivak; Liudmyla M Lazarenko; Alojz Bomba; Nadiya V Boyko
Journal:  EPMA J       Date:  2015-07-14       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.